Wide Ranks

CERS

Cerus Corporation

1.82

Top Statistics
Market Cap 338 M Forward PE -26.00 Revenue Growth 15.70 %
Current Ratio 2.59 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -11.19 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -37.50 Enterprise / Revenue 2.05 Price To Sales Trailing12 Months 1.92
Profitability
Profit Margins -11.19 % Operating Margins -2.09 %
Balance Sheet
Total Cash 75 M Total Cash Per Share 0.4070 Total Debt 97 M
Total Debt To Equity 180.35 Current Ratio 2.59 Book Value Per Share 0.2880
All Measures
Short Ratio 321.00 % Message Board Id finmb_26334 Shares Short Prior Month 7 M
Return On Equity -0.3831 City Concord Uuid 986b70aa-e85d-3fdd-978b-d29090a8b43b
Previous Close 1.76 First Trade Date Epoch Utc 854 M Book Value 0.2880
Beta 1.20 Total Debt 97 M Volume 653186
Price To Book 6.32 Fifty Two Week Low 1.38 Total Cash Per Share 0.4070
Total Revenue 176 M Shares Short Previous Month Date 1 B Target Median Price 4.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -2.09 %
Target Mean Price 3.90 Net Income To Common -19725000 Short Percent Of Float 0.0497
Implied Shares Outstanding 185 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 75 M
Next Fiscal Year End 1 B Revenue Per Share 0.9610 Held Percent Insiders 0.0327
Ebitda Margins -5.46 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.76 Target Low Price 2.50
Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.74 Open 1.76
Free Cashflow -9080125 State CA Dividend Yield 0.00 %
Return On Assets -0.0373 Time Zone Short Name EST Trailing Eps -0.1100
Day Low 1.76 Address1 1220 Concord Avenue Shares Outstanding 185 M
Price Hint 4 Target High Price 5.00 Website https://www.cerus.com
52 Week Change 0.1304 Average Volume 1 M Forward Eps -0.0700
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 183.90 %
Is_sp_500 False Regular Market Day High 1.84 Profit Margins -11.19 %
Debt To Equity 180.35 Fifty Two Week High 2.59 Day High 1.84
Shares Short 6 M Regular Market Open 1.76 Industry Key medical-devices
Earnings Growth 0.00 % Enterprise To Revenue 2.05 Revenue Growth 15.70 %
Shares Percent Shares Out 0.0373 Operating Cashflow -8753000 Currency USD
Time Zone Full Name America/New_York Market Cap 338 M Is_nasdaq_100 False
Zip 94520 Quote Type EQUITY Industry Medical Devices
Long Name Cerus Corporation Regular Market Day Low 1.76 Held Percent Institutions 0.7926
Current Price 1.82 Address2 Suite 600 Enterprise To Ebitda -37.50
Financial Currency USD Current Ratio 2.59 Gross Margins 55.66 %
Industry Disp Medical Devices Number Of Analyst Opinions 5 Country United States
Float Shares 157 M Two Hundred Day Average 1.93 Ir Website http://www.cerus.com/Investors/Investor-Overview/default.aspx
Enterprise Value 361 M Price To Sales Trailing12 Months 1.92 Forward PE -26.00
Regular Market Volume 653186 Ebitda -9630000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Cerus Corporation operates as a biomedical products company.

The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced.

It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally.

Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.